A Randomized Controlled Trial of a Novel Community-based Primary and Secondary Cardiovascular Prevention Program

Summary

VIP is a demonstration project with a goal to decrease modifiable risk factors for those with a higher risk of having a vascular event such as a heart attack or stroke or of developing vascular disease. Introduced as a study, VIP compares whether there is a significant reduction of modifiable vascular risk factors among patients who are involved in a personalized directed program versus those being provided standard care by their physician. Health care providers work collaboratively with the 'VIP Team' to improve the participants' vascular health.

Conditions

• Vascular Disease
• Diabetes
• Hypertension
• Hyperlipidemia
• Obesity

Interventions

BEHAVIORAL

Action Score

Improvement in a novel 100-point score summarizing cardiovascular risk.

BEHAVIORAL

VIP program

Risk assessment, lifestyle counselling, exercise program

Sponsors & Collaborators

• Ontario Ministry of Health and Long Term Care

  collaborator OTHER_GOV

• McMaster University

  collaborator OTHER

• Coalition for the Acquisition of Sound Habits

  collaborator OTHER

• Ministry of Northern Development and Mines Youth Internship Program

  collaborator UNKNOWN

• Pfizer

  collaborator INDUSTRY

• Group Health Centre

  lead OTHER

Principal Investigators

• David Crookston, MD CCFP · Algoma District Medical Group and Group Health Centre

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

30 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2004-08-31

Primary Completion

2006-07-31

Completion

2006-07-31

Countries

• Canada

Study Locations